# OnCo record paper-jiang-fuscc-tnbc-landscape-cancer-cell-2019 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-jiang-fuscc-tnbc-landscape-cancer-cell-2019/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-jiang-fuscc-tnbc-landscape-cancer-cell-2019" ;
  schema:name "Genomic and transcriptomic landscape of triple-negative breast cancers: subtypes and treatment strategies"@en ;
  schema:description "The largest Chinese triple-negative cohort, 465 patients from Fudan, carried more PIK3CA mutations than American tumours and sorted into four subtypes, with the luminal androgen receptor type showing HER2 mutations and CDKN2A loss."@en ;
  schema:url <https://onco.cc/key-papers/paper-jiang-fuscc-tnbc-landscape-cancer-cell-2019/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/j.ccell.2019.02.001>, <https://pubmed.ncbi.nlm.nih.gov/30853353/> ;
  schema:sameAs <https://doi.org/10.1016/j.ccell.2019.02.001> ;
  schema:datePublished "2019"^^xsd:gYear ;
  schema:author "Jiang YZ, Ma D, Suo C, et al." ;
  onco:cancers <https://onco.cc/cancers/tnbc/> ;
  onco:targets <https://onco.cc/targets/pik3ca/>, <https://onco.cc/targets/her2/>, <https://onco.cc/targets/cdkn2a/>, <https://onco.cc/targets/androgen-receptor/> ;
  onco:institutions <https://onco.cc/institutions/zhongshan-hospital-fudan/> ;
  onco:terms <https://onco.cc/terms/mutational-signature/> ;
  onco:people <https://onco.cc/people/jiang-yi-zhou/>, <https://onco.cc/people/shao-zhi-ming/> ;
  onco:journals <https://onco.cc/journals/cancer-cell/> .